newsfilter
← Latest News
GlobeNewswire·

Aura Biosciences to Participate in Upcoming Investor Conference

BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers,